New PDF release: Toxicological profiles - Bromodichloromethane
Read Online or Download Toxicological profiles - Bromodichloromethane PDF
Similar pharmacology books
Now in its 3rd version, High-Yield™ Pharmacology presents a succinct evaluation of pharmacology whereas clarifying tricky options. Need-to-know info is gifted in a transparent, concise define layout. extra beneficial properties comprise up-to-date drug references, a drug index, key issues in daring, and tables summarizing key evidence.
This precise quantity explores in silico tools for pharmaceutical toxicity through combining the theoretical complicated examine with the sensible software of the instruments. starting with a bit overlaying refined versions addressing the binding to receptors, pharmacokinetics and adsorption, metabolism, distribution, and excretion, the publication keeps with chapters delving into versions for particular toxicological and ecotoxicological endpoints, in addition to vast perspectives of the most projects and new views in an effort to probably increase our manner of modelling prescription drugs.
- Textbook of pharmacoepidemiology
- Drug Abuse Sourcebook, Third Edition
- Marihuana: The First Twelve Thousand Years
- Development of Vaccines: From Discovery to Clinical Testing
Extra resources for Toxicological profiles - Bromodichloromethane
This corresponds to a half-life of more than 1,000 years. Biodegradation in aqueous media may be significant in some cases. For example, Tabak et al. (1981) reported 35% transformation after seven days incubation in a medium inoculated with sewage. Repeated culturing lead to increased losses, indicating gradual adaptation of the degradative microbes. 5. POTENTIAL FOR HUMAN EXPOSURE Under aquatic conditions where volatilization cannot occur, biodegradation may be the predominant mechanism for degradation of BDCM.
1982). These doses are not significantly different from those observed to cause hepatic injury in acute and short-term studies, suggesting that there is a relatively low tendency toward cumulative injury to liver. An exception is the study of Chu et al. (1982b), where statistically significant effects on liver were noted in rats exposed to doses as low as 7 mg/kg/day for 90 days. However, these effects were minimal (the authors assigned a severity score of 2 on a scale of 1 to 10) and showed essentially no dose-response tendency.
2% in mice, and 2% to 6% in monkeys) (Mink et al. 1986; Smith et al. 1985). Fecal excretion in monkeys accounted for less than 2% of the administered dose 72 hours after dosing (Smith et al. 1985). In rats, Smith et al. (1985) found no detectable amounts of radiolabelled BDCM or metabolites in the feces, but the feces were evaluated only up to 6 hours after administration of BDCM. The shortness of the time interval does not give an accurate assessment of the feces as a route of excretion for BDCM, since 37% of the administered dose in the rats was accounted for in the gastrointestinal tract.
Toxicological profiles - Bromodichloromethane